Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Randomized Controlled Pilot Trial Of Dapagliflozin In Alzheimer's Disease
Authors not listed
Jeff Burns, MD · 2019
Abstract
This is a pilot randomized controlled trial in individuals with probable Alzheimer's disease testing the effects of 10 mg dapagliflozin, taken daily for 12 weeks, on cerebral n-acetyl aspartate (NAA) levels using magnetic resonance spectroscopy (MRS). The investigators will also examine the safety and tolerability of dapagliflozin and explore the effects on systemic NAA levels in blood and urine, cerebral metabolism (fluorodeoxyglucose \[FDG\] PET), systemic metabolic biomarkers that indicate and quantify secondary metabolic effects, and cognitive performance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2019). Randomized Controlled Pilot Trial Of Dapagliflozin In Alzheimer's Disease. <em>Jeff Burns, MD</em>. https://clinicaltrials.gov/study/NCT03801642
Vancouver
Anonymous. Randomized Controlled Pilot Trial Of Dapagliflozin In Alzheimer's Disease. Jeff Burns, MD. 2019.
BibTeX
@misc{anon2019Random,
title = {Randomized Controlled Pilot Trial Of Dapagliflozin In Alzheimer's Disease},
author = {Anonymous},
journal = {Jeff Burns, MD},
year = {2019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Neurobiology 2002
Citation only
Hypoxia Signaling to Genes: Significance in Alzheimer's Disease
University of Colorado, Denver 2024
Open access · US-GOV
Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial
Shanghai Mental Health Center 2017
Open access · US-GOV
Phase III Trial of Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease: a 26 Weeks, Randomized, Double-blind, Double-dummy, Placebo- and Positive- Parallel Controlled and Extended Single Arm to 54 Weeks Multicentre Study
University of Florida 2019
Open access · US-GOV
Enhancing Cognition in Older Adults With Intermittent Hypoxia and Cognitive Training: The EXCITE Study
Trials 2024
Open access · CC-BY
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) in elderly patients: Study protocol for a multicenter, randomized, adaptive allocation clinical trial
Hebrew SeniorLife 2015
Open access · US-GOV